Read the US chapter of RPC's 2026 Annual Insurance Review, authored by Hinshaw partners Scott Seaman and Pedro Hernandez, who address a wide array of critical insurance developments and topics.

Read the annual Mealey’s commentary by Hinshaw insurance attorneys Scott Seaman, Pedro Hernandez, and Jordan Evans, which looks back at significant insurance trends, regulations, and landmark case rulings from 2025, along with practical takeaways and predictions for 2026.

Read Francesco Palanda's byline titled "Best Practices in Presenting Business Interruption Claims," which was published in an American Bar Association Insurance Committee newsletter and outlines essential strategies for handling business interruption claims for catastrophic losses.

Read our latest alert explaining why regulating rate controls can backfire—driving up costs, lowering availability, and risking insolvency—while highlighting litigation costs and “social inflation” as key factors increasing premiums.

Per- and poly-fluoroalkyl substances ("PFAS") represent major exposures to insurers and their policyholders. Thousands of lawsuits are pending nationwide, and numerous large settlements have already been reached. Insurers are facing claims, tenders, and coverage actions from policyholders seeking defense and indemnity for PFAS-related claims. The plaintiffs' bar is focused on PFAS and views these so-called "forever chemicals" as a fertile source of lawsuits and large recoveries.

Per and polyfluoroalkyl substances (PFAS) represent major exposures to insurers and their policyholders. Thousands of lawsuits are pending nationwide and several large settlements have already been reached. Insurers are facing claims, tenders, and coverage actions from policyholders seeking defense and indemnity for PFAS-related claims. The plaintiff's bar is focused on PFAS and views these so-called forever chemicals as a fertile source of lawsuits and large recoveries. Though late to the game, federal and state regulators are now locked and loaded on regulating these substances in significant ways. Whether or not PFAS-related liabilities present losses to the insurance industry that will rival asbestos-related liabilities remains to be seen. Nonetheless, insurers are preparing for numerous claims and large losses. In this article[i], we provide some background on PFAS exposures and identity some of the many coverage issues that may be presented in PFAS-related coverage litigation.